# Dr. Bruce G. Rankin, DO, Deland, FL – FDA Inspections

Source: https://www.keypedia.com/companies/dr-bruce-g-rankin-do/e17db3fc-0266-4df0-9179-eb664fb264cb

> Inspection records and compliance data for Dr. Bruce G. Rankin, DO in Deland, Florida. 6 FDA inspections on record, 1 Form 483, last inspected September 22, 2023.

---

## Details

- Name: Dr. Bruce G. Rankin, DO
- FEI Number: 3006528394
- Address Line 1: 860 Peachwood Dr
- City: Deland
- State: Florida
- Zip Code: 32720
- Country Name: United States
- Address: 860 Peachwood Dr, Deland, Florida 32720, United States
- Country: United States

## Related Documents

- [483 - Dr. Bruce G. Rankin, DO - 2023-09-22](https://www.keypedia.com/records/483/dr-bruce-g-rankin-do/08cf5ded-135d-4c36-a218-5ccc4f3bfd61) — source: FDA, date: September 22, 2023
- [FDA Inspection 1218367 - Dr. Bruce G. Rankin, DO - 2023-09-22](https://www.keypedia.com/records/fda_inspections/dr-bruce-g-rankin-do/fa7388fb-83c0-415e-ac47-352c64837f6a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 22, 2023
- FDA Inspection 1133732 - Dr. Bruce G. Rankin, DO - 2020-11-24 — classification: No Action Indicated (NAI), source: FDA, date: November 24, 2020
- FDA Inspection 1133732 - Dr. Bruce G. Rankin, DO - 2020-11-24 — classification: No Action Indicated (NAI), source: FDA, date: November 24, 2020
- [FDA Inspection 927571 - Dr. Bruce G. Rankin, DO - 2015-05-08](https://www.keypedia.com/records/fda_inspections/dr-bruce-g-rankin-do/04a03367-8ee7-46d3-ae50-ed3ecbc6fc94) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 8, 2015
- FDA Inspection 867756 - Dr. Bruce G. Rankin, DO - 2014-02-25 — classification: No Action Indicated (NAI), source: FDA, date: February 25, 2014
- FDA Inspection 642563 - Dr. Bruce G. Rankin, DO - 2010-01-26 — classification: No Action Indicated (NAI), source: FDA, date: January 26, 2010
- [FDA Inspection 646078 - Dr. Bruce G. Rankin, DO - 2010-01-12](https://www.keypedia.com/records/fda_inspections/dr-bruce-g-rankin-do/12a208d9-8b16-4284-9c95-abc930c5b10b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 12, 2010

## Related Companies

- [Concentrics Research, LLC](https://www.keypedia.com/companies/concentrics-research-llc/a997494c-f897-4f26-8635-a8209cc38a2c)
- [John M. Kirkwood, MD](https://www.keypedia.com/companies/john-m-kirkwood-md/fe0085cd-4b37-44c2-ba07-d1aa198b9925)
- [Corey G. Anderson, M.D.](https://www.keypedia.com/companies/corey-g-anderson-md/a4e1398f-d75f-4df2-a4a1-567d96132e60)
- [St. Jude Children's Research Hospital](https://www.keypedia.com/companies/st-jude-childrens-research-hospital/821a4e4c-3929-4e0f-8d44-7b2217d1889f)
- [Rosa M. Suarez, M.D.](https://www.keypedia.com/companies/rosa-m-suarez-md/62922b39-e983-49af-acd4-6c6790c7943b)
- [Beth E. Safirstein, M.D.](https://www.keypedia.com/companies/beth-e-safirstein-md/9fdf7e95-e050-4f9d-bcd2-e00665e881c1)
- [Seton Family of Hospitals Institutional Review Board (SFOH IRB)](https://www.keypedia.com/companies/seton-family-of-hospitals-institutional-review-board-sfoh-irb/d1a6b405-85e7-47f6-9180-2b73ad35df67)
- [Ernie Riffer MD](https://www.keypedia.com/companies/ernie-riffer-md/469fbcc7-4a15-4de7-ab85-aa2f05772854)
- [RxCrossroads 3PL LLC](https://www.keypedia.com/companies/rxcrossroads-3pl-llc/e9481857-3430-4246-9b9d-1b0cbbb34385)
- [Lonza Biologics, Inc.](https://www.keypedia.com/companies/lonza-biologics-inc/65c37877-cae1-4065-aca5-ae3cddfb008a)

## Related Officers

- [investigator](https://www.keypedia.com/people/emily-a-baldwin/92d70174-7029-44f4-af30-e3230d4e9507)
